Study: Methods used to manage post-TAVR patients are safe

01/22/2013 | Healio

Warfarin plus a single antiplatelet drug or, if bleeding is an issue, warfarin alone were safe for patients following transcatheter aortic valve replacement, according to a study in the American Journal of Cardiology. "In general, we believe that patients who have indications for long-term anticoagulation should continue with this therapy irrespective of the TAVR procedure," the study's authors wrote.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC